CN100348244C - Method for making traditional Chinese medicine for treating hyperosteogeny - Google Patents
Method for making traditional Chinese medicine for treating hyperosteogeny Download PDFInfo
- Publication number
- CN100348244C CN100348244C CNB2004100240923A CN200410024092A CN100348244C CN 100348244 C CN100348244 C CN 100348244C CN B2004100240923 A CNB2004100240923 A CN B2004100240923A CN 200410024092 A CN200410024092 A CN 200410024092A CN 100348244 C CN100348244 C CN 100348244C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- traditional chinese
- rhizoma
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a manufacturing method of traditional Chinese medicine for treating hyperostereogeny, which is characterized in that the present invention uses 18 kinds of traditional Chinese medicine as raw materials; each kind of traditional Chinese medicine materials accounts for the weight percentages in the compound total dosage is 3 to 7% of notoginseng, 6 to 8% of angelica, 6 to 8% of frankincense, 4 to 8% of myrrh, 4 to 8% of rhizoma drynariae, 4 to 8% of cassia twig, 3 to 7% of eupolyphaga, 4 to 10% of radix dipsaci from Sichuan of China, 3 to 7% of radix et rhizoma rhei from Sichuan of China, 4 to 8% of bletilla tuber, 4 to 8% of safflower, 4 to 9% of dragon blood, 4 to 7% of eucommia bark, 3 to 7% of catechu, 3 to 7% of sodium tetraborate decahydrate, 4 to 9% of native copper, 3 to 7% of licorice root and 3 to 7% of pawpaw. The traditional Chinese medicine for treating hyperosteogeny diseases has the characteristics of obvious curative effect and high curative rate.
Description
Affiliated technical field
The invention belongs to Chinese patent medicine pharmaceutical technology field, be specially a kind of manufacture method that is used for the treatment of the Chinese medicine of hyperosteogeny.
Background technology
At present, the medicine that is used for the treatment of hyperosteogeny in the society has many kinds, though these medicines respectively have its certain curative effect, therapeutic effect is not obvious, cure rate is lower, and this is the existing various common defects that the hyperosteogeny medicine exists that is used for the treatment of.
Summary of the invention
Task of the present invention is to provide a kind of manufacture method for the treatment of the Chinese medicine of hyperosteogeny that is used for that a kind of manufacture method is simple, therapeutic effect is obvious, cure rate is high.
Task of the present invention realizes with following scheme:
It is raw material that a, batching of the present invention are taked following 18 kinds of Chinese herbal medicine: promptly: Radix Notoginseng, Radix Angelicae Sinensis, Olibanum, Myrrha, hair Rhizoma Zingiberis Recens, Ramulus Cinnamomi, Radix Dipsaci, eupolyphaga, Radix Et Rhizoma Rhei, Fructus Chaenomelis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Flos Carthami, Sanguis Draxonis, the Cortex Eucommiae, catechu, Borax, Pyritum, Radix Glycyrrhizae.
B, Chinese medicine of the present invention each composition shared percentage by weight in the compound recipe accumulated dose of preparing burden is: Radix Notoginseng 3-7%, Radix Angelicae Sinensis 6-8%, Olibanum 6-8%, Myrrha 4-8%, hair Rhizoma Zingiberis Recens 4-8%, Ramulus Cinnamomi 4-8%, eupolyphaga 3-7%, Radix Dipsaci 4-10%, the 3-7% of Radix Et Rhizoma Rhei, Pseudobulbus Bletillae (Rhizoma Bletillae) 4-8%, Flos Carthami 4-8%, Sanguis Draxonis 4-9%, Cortex Eucommiae 4-7%, catechu 3-7%, Borax 3-7%, Pyritum 4-9%, Radix Glycyrrhizae 3-7%, Fructus Chaenomelis 3-7%.
C, manufacture method of the present invention comprise: Chinese medicine is prepared burden, cleans, pulverizes, is sieved, mixing, capsule subpackage operation, promptly clean and be ground into fine powder after decontamination drains by medicinal clear water in described each flavor of a, after sieving, get even fine powder and in mixing after the described ratio proportioning of b, capsule subpackage is Chinese medicine of the present invention.
The invention has the beneficial effects as follows that the Chinese medicine made from said method has blood circulation promoting and blood stasis dispelling, the thin network of promoting blood circulation, reducing swelling and alleviating pain, liver and kidney tonifying, bone and muscle strengthening, enhancing dense structure property, bone density improving, minimizing calcium loss, strengthen the flexible effect of osteocyte.Eliminate symptom and Signs effectively with this treatment by Chinese herbs hyperosteogeny condition of disease, and have obvious treatment effect and the high characteristics of cure rate, can effectively realize task of the present invention.
The specific embodiment
Embodiment 1
The percentage by weight of each raw material in the compound recipe accumulated dose is:
Radix Notoginseng 6%, Radix Angelicae Sinensis 6%, Olibanum 6%, Myrrha 6%, hair Rhizoma Zingiberis Recens 6%, Ramulus Cinnamomi 6%, eupolyphaga 4%, Radix Dipsaci 6%, Radix Et Rhizoma Rhei 3%, the Pseudobulbus Bletillae (Rhizoma Bletillae) 6%, Flos Carthami 6%, Sanguis Draxonis 9%, the Cortex Eucommiae 6%, catechu 3%, Borax 3%, Pyritum 9%, Radix Glycyrrhizae 3%, Fructus Chaenomelis 6%.
Embodiment 2
The percentage by weight of each raw material in the compound recipe accumulated dose is:
Radix Notoginseng 3%, Radix Angelicae Sinensis 7%, Olibanum 7%, Myrrha 7%, hair Rhizoma Zingiberis Recens 7%, Ramulus Cinnamomi 7%, eupolyphaga 3%, Radix Dipsaci 7%, Radix Et Rhizoma Rhei 4%, the Pseudobulbus Bletillae (Rhizoma Bletillae) 7%, Flos Carthami 7%, Sanguis Draxonis 6%, the Cortex Eucommiae 7%, catechu 4%, Borax 4%, Pyritum 6%, Radix Glycyrrhizae 4%, Fructus Chaenomelis 3%.
Embodiment 3
The percentage by weight of each raw material in the compound recipe accumulated dose is:
Radix Notoginseng 7%, Radix Angelicae Sinensis 4%, Olibanum 4%, Myrrha 4%, hair Rhizoma Zingiberis Recens 5%, Ramulus Cinnamomi 5%, eupolyphaga 7%, Radix Dipsaci 9%, Radix Et Rhizoma Rhei 7%, the Pseudobulbus Bletillae (Rhizoma Bletillae) 4%, Flos Carthami 4%, Sanguis Draxonis 4%, the Cortex Eucommiae 4%, catechu 7%, Borax 7%, Pyritum 4%, Radix Glycyrrhizae 7%, Fructus Chaenomelis 7%.
The manufacture method of the foregoing description is all taked the described method of c, and wherein embodiment 1 is a most preferred embodiment.
Claims (1)
1, a kind of manufacture method for the treatment of the Chinese medicine of hyperosteogeny, comprise the Chinese medicine batching, clean, pulverize, sieve, mixing, the capsule subpackage operation is characterized in that the described Chinese medicine percentage by weight of each composition in the compound recipe accumulated dose of preparing burden is: Radix Notoginseng 3-7%, Radix Angelicae Sinensis 6-8%, Olibanum 6-8%, Myrrha 4-8%, hair Rhizoma Zingiberis Recens 4-8%, Ramulus Cinnamomi 4-8%, eupolyphaga 3-7%, Radix Dipsaci 4-10%, the 3-7% of Radix Et Rhizoma Rhei, Pseudobulbus Bletillae (Rhizoma Bletillae) 4-8%, Flos Carthami 4-8%, Sanguis Draxonis 4-9%, Cortex Eucommiae 4-7%, catechu 3-7%, Borax 3-7%, Pyritum 4-9%, Radix Glycyrrhizae 3-7%, Fructus Chaenomelis 3-7%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100240923A CN100348244C (en) | 2004-05-17 | 2004-05-17 | Method for making traditional Chinese medicine for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100240923A CN100348244C (en) | 2004-05-17 | 2004-05-17 | Method for making traditional Chinese medicine for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1579509A CN1579509A (en) | 2005-02-16 |
| CN100348244C true CN100348244C (en) | 2007-11-14 |
Family
ID=34581960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100240923A Expired - Fee Related CN100348244C (en) | 2004-05-17 | 2004-05-17 | Method for making traditional Chinese medicine for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100348244C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181453B (en) * | 2007-11-30 | 2010-05-26 | 高丽娟 | Chinese medicine preparation for curing orthopaedics sickness |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1177483A (en) * | 1996-09-20 | 1998-04-01 | 袁建华 | Fracture-setting capsule of promoting blood-circulation and causing muscles and joints to relax |
| CN1386534A (en) * | 2002-05-28 | 2002-12-25 | 阎欣 | Powdered medicine for setting up bone, antalgic purpose and relaxing tendons |
-
2004
- 2004-05-17 CN CNB2004100240923A patent/CN100348244C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1177483A (en) * | 1996-09-20 | 1998-04-01 | 袁建华 | Fracture-setting capsule of promoting blood-circulation and causing muscles and joints to relax |
| CN1386534A (en) * | 2002-05-28 | 2002-12-25 | 阎欣 | Powdered medicine for setting up bone, antalgic purpose and relaxing tendons |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1579509A (en) | 2005-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526691A (en) | External application plaster for treating dysmenorrhea | |
| CN101129620A (en) | Traditional Chinese medicine for treating nasosinusitis headache | |
| CN103638370A (en) | Traditional Chinese medicine for treating dental ulcer | |
| ZHAO et al. | Prevention and treatment of osteoporosis with Chinese herbal medicines | |
| CN112843207A (en) | Formula and preparation method of smearing type thermal moxibustion ointment | |
| CN101130000A (en) | Traditional Chinese medicine for treating postoperative constipation | |
| CN103285207B (en) | Miao medicine for treating dysfunctional uterine bleeding and preparation method thereof | |
| CN104147502A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of traditional Chinese medicine composition | |
| CN104524159A (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
| CN1275636C (en) | Chinese medicine oral powder and plaster for treating rheumatism and rheumatoid disease and their prepn process | |
| CN104000933A (en) | Traditional Chinese medicine oral liquid for treating osteoproliferation | |
| CN103223079B (en) | Oral administration lipoma treatment traditional Chinese medicine composition and preparation method thereof | |
| CN100348244C (en) | Method for making traditional Chinese medicine for treating hyperosteogeny | |
| CN102451449A (en) | Capsule for warming channel to remove coldness | |
| CN102038920A (en) | Pulse-invigorating capsule | |
| CN102078501A (en) | Traditional Chinese medicine pill for treating subcutaneous nodule | |
| CN101406606A (en) | Plaster for treating rheumatism paralysis, hyperosteogeny and aches of neck, shoulder, waist and leg | |
| CN103100010A (en) | Drug for treatment of rheumatic arthritis | |
| CN103285105B (en) | Traditional Chinese medicine for treating sciatica and preparation method thereof | |
| CN101716296A (en) | Traditional Chinese medicine pill for treating psoriasis | |
| CN101239140A (en) | Chinese medicine for treating psoriasis | |
| CN103800497A (en) | Composition for treating wind-cold type influenza as well as formulation and preparation method of composition | |
| CN104826043A (en) | Chinese medicinal formula for treating crural sprain | |
| CN105343705A (en) | Rheumatoid arthritis treatment medicine | |
| CN1698801A (en) | Capsule for treating hemiplegia and rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |